BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4611759)

  • 21. Treatment of diabetes insipidus with DDAVP.
    Kikugawa CA; Cortopassi RF; Ditmer DG; Okamoto WS
    Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term experience with treatment of diabetes insipidus with synthetic analogues of neurohypophyseal hormones].
    Pacovský V; Holecek V
    Sb Lek; 1976 Jun; 78(6):149-55. PubMed ID: 951572
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
    Coculescu M; Antipa C; Cucu C
    Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetes insipidus. Diagnosis and treatment with DDAVP (Minurin)].
    Steiness I
    Ugeskr Laeger; 1976 Jun; 138(25):1505-10. PubMed ID: 936314
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Response to vasopressin analogues in diabetes insipidus.
    N Engl J Med; 1976 Aug; 295(7):393-4. PubMed ID: 778620
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus].
    Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of DDAVP in children's diabetes insipidus].
    Raska B; Straková M; Holecek V
    Cesk Pediatr; 1973; 28(5):262-4. PubMed ID: 4710286
    [No Abstract]   [Full Text] [Related]  

  • 29. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP].
    Flachsbarth F; Wilhelms E
    MMW Munch Med Wochenschr; 1982 May; 124(19):485-6. PubMed ID: 6810116
    [No Abstract]   [Full Text] [Related]  

  • 31. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
    Zancaner F; Griner A; Galante E
    Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DDAVP in treatment of vasopressin-sensitive diabetes insipidus.
    Ward MK; Fraser TR
    Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [DDAVP in the treatment of hypophyseal diabetes, nocturnal enuresis and in rapid determination of the concentrating function of the kidney].
    Likhardus V; Nemetova V; Legotska V
    Sov Med; 1976 Oct; (10):106-9. PubMed ID: 1023360
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of DDAVP in a case of familial hypothalamo-pituitary diabetes insipidus].
    Filipponi P; Nicoletti I; Nunzi E; Benedetti Massi M; Santeusanio F
    Minerva Med; 1979 Jan; 70(4):347-56. PubMed ID: 431863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A vasopressin analogue in treatment of diabetes insipidus.
    Kauli R; Laron Z
    Arch Dis Child; 1974 Jun; 49(6):482-5. PubMed ID: 4850356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus.
    Radó JP; Marosi J
    Horm Metab Res; 1975 Nov; 7(6):527-8. PubMed ID: 1213665
    [No Abstract]   [Full Text] [Related]  

  • 39. [Central and nephrogenic diabetes insipidus. Use of the intravenous DDAVP test].
    Vanelli M; Bernasconi S; Giovannelli G
    Minerva Pediatr; 1977 Mar; 29(10):721-5. PubMed ID: 875941
    [No Abstract]   [Full Text] [Related]  

  • 40. Improved psychological status of children under DDAVP therapy for central diabetes insipidus.
    Waggoner RW; Slonim AE; Armstrong SH
    Am J Psychiatry; 1978 Mar; 135(3):361-2. PubMed ID: 626231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.